Skip to content

Enovis ENOV Total Equity

Total Equity at other companies

Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$12.67B+2.2%
ESAB logo
ESABESAB
$2.19B+14.7%
Vericel logo
VericelVCEL
$356.23M+20.6%
Globus Medical logo
Globus MedicalGMED
$4.73B+15.8%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$3.08B+1.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's total equity?
Enovis (ENOV) reported total equity of $1.48B in Q1 2026.
How has Enovis's total equity changed year-over-year?
Enovis's total equity decreased by 43.6% year-over-year, from $2.62B to $1.48B.
What is the long-term trend for Enovis's total equity?
Over 5 years (2020 to 2025), Enovis's total equity has grown at a -15.9% compound annual growth rate (CAGR), from $3.54B to $1.49B.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.